George C. Clark - 10 Jan 2022 Form 4 Insider Report for Biohaven Pharmaceutical Holding Co Ltd.

Role: VP, Chief Accounting Officer
Signature: /s/ George Clark
Issuer symbol: N/A
Transactions as of: 10 Jan 2022
Net transactions value: -$59,796
Form type: 4
Filing time: 12 Jan 2022, 20:12:52 UTC
Previous filing: 07 Jan 2022
Next filing: 24 Jan 2022
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	BHVN	Common Shares	Options Exercise	$0	+1,000	+11%	$0.000000	10,184	10 Jan 2022	Direct
transaction	BHVN	Common Shares	Tax liability	$59,796	-464	-4.6%	$128.87^*	9,720	10 Jan 2022	Direct	F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	BHVN	Restricted Share Unit Award	Options Exercise	$0	-1,000	-50%	$0.000000	1,000	10 Jan 2022	Common Shares	1,000		Direct	F2, F3, F4

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	No shares were sold - these shares were withheld by the Issuer to satisfy tax withholding requirements in connection with the vesting of restricted share units.
F2	Each restricted share unit represents the contingent right to receive one common share of the Issuer.
F3	The reporting person was granted 4,000 restricted share units on January 8, 2020, vesting in four equal installments on January 8, 2020, 2021, 2022 and 2023, subject to the reporting person's continued service with the Issuer at each vesting date.
F4	Not applicable.